UR
AGN

USCA RIA’s Allergan plc AGN Stock Holding History

USCA RIA’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-18,246
Closed -$3.23M – 480
2020
Q1 		$3.23M Sell
18,246
-189
-1% -$35.6K 0.37% 62
2019
Q4 		$3.52M Sell
18,435
-346
-2% -$62.4K 0.32% 98
2019
Q3 		$3.16M Sell
18,781
-29
-0.2% -$4.72K 0.31% 94
2019
Q2 		$3.15M Buy
18,810
+10,478
+126% +$1.45M 0.32% 97
2019
Q1 		$1.22M Buy
8,332
+1,078
+15% +$156K 0.13% 184
2018
Q4 		$970K Sell
7,254
-217
-3% -$35.6K 0.13% 189
2018
Q3 		$1.42M Buy
7,471
+443
+6% +$81.4K 0.14% 190
2018
Q2 		$1.17M Buy
7,028
+606
+9% +$97.3K 0.13% 202
2018
Q1 		$1.08M Buy
6,422
+1,287
+25% +$216K 0.12% 211
2017
Q4 		$840K Sell
5,135
-827
-14% -$148K 0.09% 229
2017
Q3 		$1.45M Hold
5,962
– – 0.19% 155
2017
Q2 		$1.45M Sell
5,962
-1,855
-24% -$436K 0.19% 156
2017
Q1 		$1.87M Sell
7,817
-651
-8% -$152K 0.27% 124
2016
Q4 		$1.78M Buy
8,468
+202
+2% +$41.8K 0.27% 114
2016
Q3 		$1.9M Buy
8,266
+270
+3% +$66K 0.32% 94
2016
Q2 		$1.85M Buy
7,996
+2,921
+58% +$673K 0.31% 92
2016
Q1 		$1.36M Buy
5,075
+733
+17% +$210K 0.25% 116
2015
Q4 		$1.36M Buy
4,342
+1,097
+34% +$327K 0.29% 103
2015
Q3 		$882K Sell
3,245
-210
-6% -$64.5K 0.22% 136
2015
Q2 		$1.05M Buy
3,455
+388
+13% +$116K 0.28% 110
2015
Q1 		$913K Buy
+3,067
New +$874K 0.24% 124

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

USCA RIA's AGN Position: Q2 2020 in Review

USCA RIA sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 18,246 shares — an estimated $3.23M sold.

USCA RIA first reported a position in AGN in Q1 2015 and held it in 21 quarters. The position peaked at $3.52M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • USCA RIA reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • USCA RIA sold 18,246 Allergan plc shares in Q2 2020, an estimated $3.23M.
  • USCA RIA first reported a position in Allergan plc in Q1 2015 and held it in 21 quarters.
  • USCA RIA's Allergan plc position peaked at $3.52M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on USCA RIA's 13F filing for Q2 2020, filed 13 Aug 2020.